Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Antibiotic Selection00:57

Antibiotic Selection

55.4K
Overview
55.4K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

264
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
264
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

389
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
389
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

220
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
220
Antimicrobial Proteins01:23

Antimicrobial Proteins

6.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
6.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Discovery and Biosynthesis of the Novel Glycotetrapeptide Antibiotic Biffamycin A.

Angewandte Chemie (International ed. in English)·2026
Same author

A platform for CRISPRi-seq in <i>Streptomyces albidoflavus</i>.

mBio·2026
Same author

Antibiotics from rare actinomycetes, beyond the genus Streptomyces.

Current opinion in microbiology·2023
Same author

The N-terminal substrate specificity of the SurE peptide cyclase.

Organic & biomolecular chemistry·2022
Same author

ActinoBase: tools and protocols for researchers working on <i>Streptomyces</i> and other filamentous actinobacteria.

Microbial genomics·2022
Same author

A Standalone β-Ketoreductase Acts Concomitantly with Biosynthesis of the Antimycin Scaffold.

ACS chemical biology·2021

関連する実験動画

Updated: Sep 22, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K

オーダーメイドの抗生物質

Ryan F Seipke1

  • 1Faculty of Biological Sciences, Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Science (New York, N.Y.)
|May 26, 2022
PubMed
まとめ

新しいリポペプチド抗生物質は 多剤耐性菌に対する有望な解決策です これらの新しい化合物は 既存の薬で治療が難しくなる感染症と戦う上で 極めて重要です

科学分野:

  • 微生物学
  • 感染症
  • 薬理学について

背景:

  • 多剤耐性のバクテリアの増加は 世界的な健康上の重大な脅威となっています
  • 既存の抗生物質のクラスは 耐性メカニズムにより効果が低下しています
  • 耐性感染症との闘いには 新しい治療戦略が急に必要である.

研究 の 目的:

  • 新しいリポペプチド抗生物質の可能性を 探求するためです
  • 多剤耐性菌株に対する有効性を評価する.
  • 耐性細菌感染症の治療のための新薬候補を特定する.

主な方法:

  • 新型リポペプチド化合物の合成と特徴付け
  • 多剤耐性バクテリアのパネルに対するインビトロ感受性試験
  • リポペプチドがバクテリアの増殖を阻害する仕組みを理解する研究.

主要な成果:

  • 新しく開発されたリポペプチド抗生物質は,多剤耐性細菌病原体に対する強力な活性を示した.
  • 最低抑制濃度 (MIC) は,既定の抗生物質と比較して有意に低かった.
  • 予備的な研究は,既存の耐性経路を回避する新たな作用メカニズムを示唆している.

さらに関連する動画

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Site-specific Bacterial Chromosome Engineering: &#934;C31 Integrase Mediated Cassette Exchange (IMCE)
08:21

Site-specific Bacterial Chromosome Engineering: ΦC31 Integrase Mediated Cassette Exchange (IMCE)

Published on: March 16, 2012

15.7K

関連する実験動画

Last Updated: Sep 22, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.0K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Site-specific Bacterial Chromosome Engineering: &#934;C31 Integrase Mediated Cassette Exchange (IMCE)
08:21

Site-specific Bacterial Chromosome Engineering: ΦC31 Integrase Mediated Cassette Exchange (IMCE)

Published on: March 16, 2012

15.7K

結論:

  • リポペプチド抗生物質は,多剤耐性細菌感染と戦うための有望な新種の治療薬です.
  • これらの化合物を臨床適用に向けて進めるため,さらなる研究と開発が必要である.
  • これらの発見は 抗生物質耐性という重大な問題に取り組むための希望を与えてくれます